{"content_type":"Announcements","title":"Announcing the Data \u0026 AI Fueling R\u0026D of Tomorrow QuickFire Challenge: Singapore \u0026 Beyond","sub_title":null,"cover_image":"https:\/\/juniverseadmin.jnjinnovation.com\/sites\/default\/files\/news\/Data%20%26%20AI%20announcement%20card.jpg","slider_image":null,"another_slider_image":null,"brightcove_account":"3198958923001","brightcove_player":"9Z7fsGThCO","header_video":null,"tags":[],"focus_area":["Data Science"],"region":"Global","published_date":"2025-11-20","highlighted_text":[],"author_name":null,"author_nid":null,"meta_tags":null,"news_detail_url":null,"body":{"body":[{"paragraph_type":"text","text":[{"value":"\u003Cp\u003E\u003Cspan\u003ENovember 20, 2025 \u2013 Today, Johnson \u0026amp; Johnson announced the launch of the \u003C\/span\u003E\u003Ca href=\u0022https:\/\/jnjinnovation.com\/innovation-challenges\/Data-AI-Fueling-RnD-of-Tomorrow-QuickFire-Challenge-Singapore-Beyond\u0022\u003E\u003Cspan\u003E\u003Cstrong\u003EData \u0026amp; AI Fueling R\u0026amp;D of Tomorrow QuickFire Challenge: Singapore \u0026amp; Beyond\u003C\/strong\u003E\u003C\/span\u003E\u003C\/a\u003E\u003Cspan\u003E. The initiative invites innovators from Singapore or across the globe, with a demonstrated interest in leveraging the Singapore ecosystem, to submit their novel AI\/ML strategies and approaches to augmented science that have the potential to transform drug discovery and research.\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003EThe innovators with the most promising potential solutions aligned to this QuickFire Challenge will have the opportunity to receive\u0026nbsp;award funding from a total pool of up to $400,000 and mentorship from experts across Johnson \u0026amp; Johnson. Select awardees may also receive JLABS Singapore membership.*\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003EThe convergence of science and technology has sparked new possibilities in our pursuit to develop life-changing new medicines for patients. New AI-driven tools and models, coupled with advances in data science and digital health, have researchers reimagining the drug discovery and development process from target identification and validation through preclinical testing and clinical research.\u003Csup\u003E1,2 \u003C\/sup\u003EThese emerging technologies have the potential to drive productivity and operational efficiencies, while also advancing data collection and analysis capabilities, all with the promise of transforming our ability to efficiently and effectively conduct research and treat disease with precision.\u003Csup\u003E3\u003C\/sup\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003EAt the same time, the Asia Pacific region has emerged as an engine for innovation. Singapore, in particular, is driving growth in science and technology bolstered by government investment, world-class infrastructure, and a supportive regulatory environment.\u003Csup\u003E4\u003C\/sup\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003ESpecific areas of interest from innovators in Singapore and beyond include:\u003C\/span\u003E\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Cspan\u003EFoundation models and multi-omics capabilities\u0026nbsp;for uncovering novel biology\u003C\/span\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan\u003EVirtual disease models and validation platforms\u0026nbsp;to interrogate complex biological mechanisms\u003C\/span\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan\u003EComputer vision and digital health tools\u0026nbsp;that enable precision medicine\u003C\/span\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan\u003EGenerative AI and agentic frameworks\u0026nbsp;to extract insights from large datasets, enhance scientific workflows, and boost R\u0026amp;D productivity\u003C\/span\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003E\u003Cspan\u003E\u003Cstrong\u003ENot\u003C\/strong\u003E in scope for this challenge:\u003C\/span\u003E\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Cspan\u003ELife science tools developers (e.g., equipment, devices, reagents) or medical devices\u003C\/span\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan\u003EContract research organizations\u003C\/span\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan\u003EPatient or physician-facing apps (e.g., IoT\/Connected sensors for patient monitoring, health counseling chatbots)\u003C\/span\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003E\u003Cspan\u003EThe deadline to apply is February 20, 2026:\u0026nbsp;\u003C\/span\u003E\u003Ca href=\u0022https:\/\/jji.jnj\/DataAISingapore\u0022 target=\u0022_blank\u0022\u003E\u003Cspan\u003Ehttps:\/\/jji.jnj\/DataAISingapore\u003C\/span\u003E\u003C\/a\u003E\u003Cspan\u003E\u0026nbsp;\u003C\/span\u003E\u003C\/p\u003E\u003Cdiv class=\u0022foot\u0022 style=\u0022font-size:large;\u0022\u003E\u003Cp\u003E\u003Cspan\u003E\u003Csup\u003E*\u003C\/sup\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cspan\u003E\u003Csub\u003ESubject to terms and conditions of applicable QuickFire Challenge and execution of an award agreement\u003C\/sub\u003E\u003C\/span\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003E\u003Csup\u003E1\u003C\/sup\u003E \u003Csub\u003ESerrano DR, et al. Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine. \u003C\/sub\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cspan\u003E\u003Csub\u003EPharmaceutics\u003C\/sub\u003E\u003C\/span\u003E\u003C\/em\u003E\u003Cspan\u003E\u003Csub\u003E. 2024 Oct 14;16(10):1328. doi:\u0026nbsp;\u003C\/sub\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11510778\/\u0022 target=\u0022_blank\u0022\u003E\u003Cspan\u003E\u003Csub\u003E10.3390\/pharmaceutics16101328\u003C\/sub\u003E\u003C\/span\u003E\u003C\/a\u003E\u003Cspan\u003E\u003Csub\u003E.\u0026nbsp;\u003C\/sub\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003E\u003Csup\u003E2\u003C\/sup\u003E \u003Csub\u003EZhang K, et al. Artificial intelligence in drug development. \u003C\/sub\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cspan\u003E\u003Csub\u003ENat Med\u003C\/sub\u003E\u003C\/span\u003E\u003C\/em\u003E\u003Cspan\u003E\u003Csub\u003E. 2025 Jan;31(1):45-59. doi:\u0026nbsp;\u003C\/sub\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/pubmed.ncbi.nlm.nih.gov\/39833407\/\u0022 target=\u0022_blank\u0022\u003E\u003Cspan\u003E\u003Csub\u003E10.1038\/s41591-024-03434-4\u003C\/sub\u003E\u003C\/span\u003E\u003C\/a\u003E\u003Cspan\u003E\u003Csub\u003E.\u0026nbsp;\u003C\/sub\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003E\u003Csup\u003E3\u003C\/sup\u003E \u003Csub\u003EDoron G, Genway S, Roberts M, Jasti S. Generative AI: driving productivity and scientific breakthroughs in pharmaceutical R\u0026amp;D. \u003C\/sub\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cspan\u003E\u003Csub\u003EDrug Discov Today\u003C\/sub\u003E\u003C\/span\u003E\u003C\/em\u003E\u003Cspan\u003E\u003Csub\u003E. 2025 Jan;30(1):104272. doi:\u0026nbsp;\u003C\/sub\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/pubmed.ncbi.nlm.nih.gov\/39675517\/\u0022 target=\u0022_blank\u0022\u003E\u003Cspan\u003E\u003Csub\u003E10.1016\/j.drudis.2024.104272\u003C\/sub\u003E\u003C\/span\u003E\u003C\/a\u003E\u003Cspan\u003E\u003Csub\u003E.\u0026nbsp;\u003C\/sub\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003E\u003Csup\u003E4\u003C\/sup\u003E \u003Csub\u003EBain \u0026amp; Company. Empowering Biotech Innovation in Asia-Pacific.\u0026nbsp;\u003C\/sub\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/www.bain.com\/insights\/empowering-biotech-innovation-in-asia-pacific\/\u0022 target=\u0022_blank\u0022\u003E\u003Cspan\u003E\u003Csub\u003Ehttps:\/\/www.bain.com\/insights\/empowering-biotech-innovation-in-asia-pacific\/\u003C\/sub\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/p\u003E\u003C\/div\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","format":"full_html"}]},{"paragraph_type":"text","text":[{"value":"\u003Cp\u003E\u003Cspan\u003E\u003Cstrong\u003EAbout Johnson \u0026amp; Johnson\u0026nbsp;\u003C\/strong\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan\u003EJohnson \u0026amp; Johnson works across the innovative medicine and medical technology sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world. We do this by\u0026nbsp;harnessing our deep scientific capabilities coupled with a wide range of tools, including customized deal structures, company creation, incubation and startup services, capital investments and other innovative business models that aim to meet the diverse needs of entrepreneurs, scientists, and emerging companies. Our goal is to help life science and health technology innovations thrive through collaboration and partnership with the global ecosystem, so that together we can change the trajectory of human health. Meet our passionate team of science and technology experts and learn how to collaborate with us at\u0026nbsp;\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.jnjinnovation.com\/\u0022\u003E\u003Cspan\u003Ewww.jnjinnovation.com\u003C\/span\u003E\u003C\/a\u003E\u003Cspan\u003E.\u003C\/span\u003E\u003C\/p\u003E","format":"basic_html"}]}]},"related_news":[{"title":"Announcing the Reimagining Human Model Systems QuickFire Challenge","nid":"145192","cover_image":"https:\/\/juniverseadmin.jnjinnovation.com\/sites\/default\/files\/news\/SG%20Human%20Models%20QFC%20Announcement%20%282%29.jpg","slider_image":null,"anither_slider_image":null,"brightcove_account":"3198958923001","header_video":null,"focus_area":["Discovery Product Development \u0026 Supply"],"region":"Global","published_date":"2026-09-28","news_detail_url":null,"author_name":null,"author_nid":null,"news_type":"Announcements","brightcove_player":"9Z7fsGThCO"},{"title":"Announcing the Expanding Access to Immunology Clinical Trials QuickFire Challenge","nid":"145170","cover_image":"https:\/\/juniverseadmin.jnjinnovation.com\/sites\/default\/files\/news\/IMM%20Social%20Cards%20LIX%202P%201%20%282%29%20%281%29.jpg","slider_image":null,"anither_slider_image":null,"brightcove_account":"3198958923001","header_video":null,"focus_area":["Immunology","Innovation","Innovation Challenges"],"region":"Global","published_date":"2026-07-30","news_detail_url":null,"author_name":null,"author_nid":null,"news_type":"Announcements","brightcove_player":"9Z7fsGThCO"},{"title":"Announcing the Advancing Intratumoral Treatments QuickFire Challenge: Korea \u0026 Beyond","nid":"145156","cover_image":"https:\/\/juniverseadmin.jnjinnovation.com\/sites\/default\/files\/news\/INTO%20QFC%20Announcement%20Red.jpg","slider_image":null,"anither_slider_image":null,"brightcove_account":"3198958923001","header_video":null,"focus_area":["Interventional Oncology","Innovation","Innovation Challenges"],"region":"Global","published_date":"2026-07-27","news_detail_url":null,"author_name":null,"author_nid":null,"news_type":"Announcements","brightcove_player":"9Z7fsGThCO"},{"title":"Announcing the Transforming Oral Peptide Delivery QuickFire Challenge","nid":"145134","cover_image":"https:\/\/juniverseadmin.jnjinnovation.com\/sites\/default\/files\/news\/Oral%20Peptide%20QFC%20Announcement%201.jpg","slider_image":null,"anither_slider_image":null,"brightcove_account":"3198958923001","header_video":null,"focus_area":["Immunology","Innovation","Innovation Challenges"],"region":"Global","published_date":"2026-07-22","news_detail_url":null,"author_name":null,"author_nid":null,"news_type":"Announcements","brightcove_player":"9Z7fsGThCO"},{"title":"Announcing the Deep Tissue Healing QuickFire Challenge","nid":"145119","cover_image":"https:\/\/juniverseadmin.jnjinnovation.com\/sites\/default\/files\/news\/Deep%20Tissue%20News%20Announcement-TM.jpg","slider_image":null,"anither_slider_image":null,"brightcove_account":"3198958923001","header_video":null,"focus_area":["Immunology","Innovation","Innovation Challenges"],"region":"Global","published_date":"2026-07-16","news_detail_url":null,"author_name":null,"author_nid":null,"news_type":"Announcements","brightcove_player":"9Z7fsGThCO"}]}